Department of Microbiology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan
Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan.
J Virol. 2020 Jun 1;94(12). doi: 10.1128/JVI.00193-20.
Cell entry by HIV-1 is mediated by its principal receptor, CD4, and a coreceptor, either CCR5 or CXCR4, with viral envelope glycoprotein gp120. Generally, CCR5-using HIV-1 variants, called R5, predominate over most of the course of infection, while CXCR4-using HIV-1 variants (variants that utilize both CCR5 and CXCR4 [R5X4, or dual] or CXCR4 alone [X4]) emerge at late-stage infection in half of HIV-1-infected individuals and are associated with disease progression. Although X4 variants also appear during acute-phase infection in some cases, these variants apparently fall to undetectable levels thereafter. In this study, replication-competent X4 variants were isolated from plasma of drug treatment-naive individuals infected with HIV-1 strain CRF01_AE, which dominantly carries viral RNA (vRNA) of R5 variants. Next-generation sequencing (NGS) confirmed that sequences of X4 variants were indeed present in plasma vRNA from these individuals as a minor population. On the other hand, in one individual with a mixed infection in which X4 variants were dominant, only R5 replication-competent variants were isolated from plasma. These results indicate the existence of replication-competent variants with different coreceptor usage as minor populations. The coreceptor switch of HIV-1 from R5 to CXCR4-using variants (R5X4 or X4) has been observed in about half of HIV-1-infected individuals at late-stage infection with loss of CD4 cell count and disease progression. However, the mechanisms that underlie the emergence of CXCR4-using variants at this stage are unclear. In the present study, CXCR4-using X4 variants were isolated from plasma samples of HIV-1-infected individuals that dominantly carried vRNA of R5 variants. The sequences of the X4 variants were detected as a minor population using next-generation sequencing. Taken together, CXCR4-using variants at late-stage infection are likely to emerge when replication-competent CXCR4-using variants are maintained as a minor population during the course of infection. The present study may support the hypothesis that R5-to-X4 switching is mediated by the expansion of preexisting X4 variants in some cases.
HIV-1 的细胞进入由其主要受体 CD4 和辅助受体 CCR5 或 CXCR4 介导,辅助受体与病毒包膜糖蛋白 gp120 结合。通常,使用 CCR5 的 HIV-1 变体(称为 R5)在感染过程的大部分时间内占主导地位,而使用 CXCR4 的 HIV-1 变体(同时使用 CCR5 和 CXCR4 的变体[R5X4 或双重]或单独使用 CXCR4 的变体[X4])在半数 HIV-1 感染者的晚期感染中出现,并与疾病进展相关。尽管 X4 变体在某些情况下也出现在急性感染期,但此后这些变体显然降至无法检测的水平。在这项研究中,从感染 HIV-1 株 CRF01_AE 的未经药物治疗的个体的血浆中分离出了复制能力强的 X4 变体,该病毒 RNA(vRNA)主要携带 R5 变体。下一代测序(NGS)证实,这些个体血浆 vRNA 中的 X4 变体序列确实作为小群体存在。另一方面,在一个混合感染个体中,X4 变体占主导地位,仅从血浆中分离出 R5 复制能力强的变体。这些结果表明,作为小群体存在具有不同辅助受体使用的复制能力强的变体。HIV-1 从 R5 到使用 CXCR4 的变体(R5X4 或 X4)的核心受体转换已在约半数晚期感染 HIV-1 的个体中观察到,导致 CD4 细胞计数丧失和疾病进展。然而,目前尚不清楚导致该阶段出现使用 CXCR4 的变体的机制。在本研究中,从携带 R5 变体主要 vRNA 的 HIV-1 感染个体的血浆样本中分离出了使用 CXCR4 的 X4 变体。使用下一代测序检测到 X4 变体的序列作为小群体存在。综上所述,在感染过程中当作为小群体维持复制能力强的使用 CXCR4 的变体时,晚期感染中使用 CXCR4 的变体可能会出现。本研究可能支持这样的假说,即在某些情况下,R5 到 X4 的转换是由预先存在的 X4 变体的扩增介导的。